Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.

Autor: Wang JH; Johns Hopkins University, Baltimore, MD, USA., Deek MP; Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA., Mendes AA; Johns Hopkins University, Baltimore, MD, USA., Song Y; Johns Hopkins University, Baltimore, MD, USA., Shetty A; University of Maryland Medical Center, Baltimore, MD, USA., Bazyar S; University of Maryland Medical Center, Baltimore, MD, USA., Van der Eecken K; Ghent University Hospital, Ghent, Belgium., Chen E; Artera Inc., Los Altos, CA, USA., Showalter TN; Artera Inc., Los Altos, CA, USA; University of Virginia, Charlottesville, VA, USA., Royce TJ; Artera Inc., Los Altos, CA, USA., Todorovic T; Artera Inc., Los Altos, CA, USA., Huang HC; Artera Inc., Los Altos, CA, USA., Houck SA; Artera Inc., Los Altos, CA, USA., Yamashita R; Artera Inc., Los Altos, CA, USA., Kiess AP; Johns Hopkins University, Baltimore, MD, USA., Song DY; Johns Hopkins University, Baltimore, MD, USA., Lotan T; Johns Hopkins University, Baltimore, MD, USA., DeWeese T; Johns Hopkins University, Baltimore, MD, USA., Marchionni L; Weill Cornell Medical College, New York, NY, USA., Ren L; University of Maryland Medical Center, Baltimore, MD, USA., Sawant A; University of Maryland Medical Center, Baltimore, MD, USA., Simone N; Thomas Jefferson University, Philadelphia, PA, USA., Berlin A; Princess Margaret Cancer Centre, Toronto, Canada., Onal C; Baskent University, Ankara, Turkey., Esteva A; Artera Inc., Los Altos, CA, USA., Feng FY; Artera Inc., Los Altos, CA, USA; University of California San Francisco, San Francisco, CA, USA., Tran PT; University of Maryland Medical Center, Baltimore, MD, USA. Electronic address: phuoc.tran@umm.edu., Sutera P; University of Rochester Medical Center, Rochester, NY, USA. Electronic address: philip_sutera@urmc.rochester.edu., Ost P; Department of Human Structure and Repair, Ghent University, Ghent, Belgium; Department of Radiation Oncology, Iridium Network, Antwerp, Belgium. Electronic address: piet.ost@ugent.be.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2024 Nov 06; Vol. 202, pp. 110618. Date of Electronic Publication: 2024 Nov 06.

Lower survival for surgical treatment of HPV-related oropharynx cancer at community cancer centers.

Autor: Trakimas DR; Dept of Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA., Mydlarz WK; Dept of Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.; Dept of Oncology, Johns Hopkins Hospital, Baltimore, MD, USA., Mady LJ; Dept of Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA., Gourin CG; Dept of Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA., Koch W; Dept of Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA., London NR Jr; Dept of Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA., Quon H; Dept of Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.; Dept of Radiation Oncology, Johns Hopkins Hospital, Baltimore, MD, USA., Kiess AP; Dept of Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.; Dept of Radiation Oncology, Johns Hopkins Hospital, Baltimore, MD, USA., Seiwert TY; Dept of Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.; Dept of Oncology, Johns Hopkins Hospital, Baltimore, MD, USA., Fakhry C; Dept of Otolaryngology-Head & Neck Surgery, Johns Hopkins Hospital, Baltimore, MD, USA.; Dept of Oncology, Johns Hopkins Hospital, Baltimore, MD, USA.

Publikováno v: Journal of the National Cancer Institute [J Natl Cancer Inst] 2024 Sep 09. Date of Electronic Publication: 2024 Sep 09.

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology.

Autor: Lapi SE; Departments of Radiology and Chemistry, O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham, AL, USA., Scott PJH; Department of Radiology, University of Michigan, Ann Arbor, MI, USA., Scott AM; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia; Department of Surgery, Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia., Windhorst AD; Department of Radiology & Nuclear Medicine, Amsterdam UMC, Amsterdam, Netherlands; Cancer Center Amsterdam, Vrije Universiteit, Amsterdam, Netherlands., Zeglis BM; Department of Chemistry, Hunter College, City University of New York, New York City, NY, USA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA; Department of Radiology, Weill Cornell Medical College, New York City, NY, USA., Abdel-Wahab M; Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Baum RP; Deutsche Klinik für Diagnostik (DKD Helios Klinik) Wiesbaden, Curanosticum MVZ Wiesbaden-Frankfurt, Center for Advanced Radiomolecular Precision Oncology, Germany., Buatti JM; Department of Radiation Oncology, University of Iowa Carver College of Medicine, Iowa City, IA, USA., Giammarile F; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria; Centre Leon Bérard, Lyon, France., Kiess AP; Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Jalilian A; Radiochemistry and Radiotechnology Section, Division of Physical and Chemical Sciences, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Knoll P; Dosimetry and Medical Radiation Physics Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Korde A; Radiochemistry and Radiotechnology Section, Division of Physical and Chemical Sciences, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Kunikowska J; Nuclear Medicine Department, Medical University of Warsaw, Warsaw, Poland., Lee ST; Department of Molecular Imaging and Therapy, Austin Health, Melbourne, VIC, Australia; Olivia Newton-John Cancer Research Institute, Melbourne, VIC, Australia; School of Cancer Medicine, La Trobe University, Melbourne, VIC, Australia; Department of Surgery, Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia., Paez D; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, Vienna, Austria., Urbain JL; Department of Radiology-Nuclear Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA., Zhang J; Department of Diagnostic Radiology, National University of Singapore, Singapore; Clinical Imaging Research Centre, Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore., Lewis JS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York City, NY, USA; Department of Radiology, Weill Cornell Medical College, New York City, NY, USA; Department of Pharmacology, Weill Cornell Medical College, New York City, NY, USA. Electronic address: lewisj2@mskcc.org.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Jun; Vol. 25 (6), pp. e236-e249.

Radiotheranostics in advanced prostate cancer: Current and future directions.

Autor: Jia AY; Department of Radiation Oncology, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA. Angela.Jia@UHhospitals.org., Kiess AP; Department of Radiation Oncology, Johns Hopkins University, Baltimore, MD, USA., Li Q; Department of Nuclear Medicine, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USA., Antonarakis ES; University of Minnesota Masonic Cancer Center, Minneapolis, MN, USA.

Publikováno v: Prostate cancer and prostatic diseases [Prostate Cancer Prostatic Dis] 2024 Mar; Vol. 27 (1), pp. 11-21. Date of Electronic Publication: 2023 Apr 14.

PSMA-targeted therapy for non-prostate cancers.

Autor: Wang JH; Department of Radiation Oncology and Molecular Radiation Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD, United States., Kiess AP; Department of Radiation Oncology and Molecular Radiation Sciences, School of Medicine, Johns Hopkins University, Baltimore, MD, United States.

Publikováno v: Frontiers in oncology [Front Oncol] 2023 Aug 14; Vol. 13, pp. 1220586. Date of Electronic Publication: 2023 Aug 14 (Print Publication: 2023).